New Delhi [India], December 7 (ANI): After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine "COVISHIELD", its CEO Adar Poonawala expressed gratitude to Prime Minister Narendra Modi and the central government for the support.
New Delhi [India], December 7 (ANI): The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine "Covishield" in the country.
New Delhi [India], December 1 (ANI): Stressing that the Covishield vaccine is "safe and immunogenic", the Serum Institute of India (SII) on Tuesday said the incident with the Chennai volunteer was in no way induced by the vaccine as "requisite regulatory and ethical processes and guideline"
New Delhi [India], November 29 (ANI): After a Chennai-based man claimed that he suffered neurological and psychological side effects after taking a shot of COVID-19 vaccine candidate Covishield during the human trial, being conducted by Serum Institute of India's (SII), the Pune-based com
New Delhi [India], November 29 (ANI): Congress leader and Rajya Sabha MP, Anand Sharma on Sunday said that Prime Minister Narendra Modi's visit to the units of three vaccine manufacturers in the country to review the progress of Covid-19 vaccine development and manufacturing process, will
Pune (Maharashtra) [India], November 28 (ANI): Hours after Prime Minister Narendra Modi visited Pune-based Serum Institute of India (SII), its Chief Executive Officer Adar Poonawalla said that he was amazed by the Prime Minister's knowledge about vaccines and vaccine production.
New Delhi [India], November 28 (ANI): After Prime Minister Narendra Modi visited the company's pandemic level facility in Pune, Serum Institute of India's (SII), Chief Executive Officer (CEO) Adar Poonawalla on Saturday said that indications suggest that the central government may purchase 3
Pune (Maharashtra) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday visited Serum Institute of India in Pune as part of efforts to get a first-hand perspective of the preparations, challenges, and roadmap in India's endeavour to vaccinate its citizens against COVID-19.
New Delhi [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday will embark on a three-city visit to personally review the vaccine development and manufacturing process.
Pune (Maharashtra) [India], November 27 (ANI): The scheduled programme of foreign envoys who were expected to review the development of COVID-19 vaccines in Pune's Serum Institute got cancelled, according to Pune's district administration on Friday.
Pune (Maharashtra) [India], November 27 (ANI): Preparations are underway at Serum Institute of India (SII) where Prime Minister Narendra Modi is expected to visit on November 28 to review the COVID-19 vaccine production and its distribution mechanisms.
Pune (Maharashtra) [India], November 26 (ANI): Prime Minister Narendra Modi will on Saturday visit Serum Institute of India, which has partnered with AstraZeneca and Oxford University for production of vaccine against COVID-19.